2025 Q4 -tulosraportti
UUTTA
4 päivää sitten37 min
4,75 NOK/osake
Irtoamispäivä 17.4.
2,48%Tuotto/v
Tarjoustasot
Oslo Børs
Määrä
Osto
5
Myynti
Määrä
220
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 174 | - | - | ||
| 100 | - | - | ||
| 125 | - | - | ||
| 125 | - | - |
Ylin
173VWAP
Alin
168,2VaihtoMäärä
21,8 128 683
VWAP
Ylin
173Alin
168,2VaihtoMäärä
21,8 128 683
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2026 Q1 -tulosraportti | 29.4. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q4 -tulosraportti | 4.2. | |
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 16.7.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 29.1.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·23 t sittenWhat do people think about this company going forward. Have followed the stock for a long time, but never owned any shares. What are the positives and negatives with the company?
·2 t sittenGood question - Podcast stockup highlights Borregaard as a safe haven, unique products, strong financials and robust. Increased dividend for a long time and approaching an aristocrat. I don't own the stock myself, followed it from the sidelines. The last I heard was a one-off cost that many viewed negatively. Hope this was helpful. Last tip look at P/E and forward P/E and forward Eps growth.
·2 päivää sittenYes, they delivered a bit weaker than expected and yes, they face competition from the Chinese. But they also delivered the best ebitda ever (just barely) in 2025. Fortunately, the price targets are far above today's price, so with a little patience, this will probably calm down soon and the bottom will be reached. The same happened with Link and they are now somewhat on their way up again. I have faith
·2 päivää sittenThe crucial point was not that China exists – they have done so for a long time – but that: Management for the first time explicitly guided price decline (–3–4 % H1 2026) in Biomaterials The sentence about Chinese imports affecting European producers was stated black on white in the presentation This hit a market that was positioned for price increases, not decreases The market interpreted this as potentially structural, not just cyclical.·2 päivää sittenYeah, I caught that. China has been discussed many times before, but this was the first time they included it in the report. So maybe they are feeling the competition more now than before, that's possible. The decline is due, as you say, to the fact that market participants expected a price increase for biomaterials (vanillin) while the company announced a decrease. Let's hope they were a bit conservative in their guiding.
2 päivää sitten2 päivää sittenDo we hold the line, or is it the last man out the door to turn the lights off? Where are the triggers ?
·3 päivää sittenABG Sundal Collier BUY price target 210 kroner (220) recommendation after the fourth-quarter report, according to an update Thursday. DNB Carnegie BUY unchanged price target of 240 kroner, according to an update Wednesday. Danske Bank HOLD price target 195 kroner (215), according to an update Wednesday. Pareto Securities reiterates HOLD price target 196 kroner (208) SEB downgrades to HOLD , price target to 200 kroner (230). https://www.nordnet.no/market/news/601bb631-5543-45b4-a4aa-89c4c048ebf5 . https://www.nordnet.no/market/news/ed81d193-c4ec-44c0-ab1c-7bd893df389f
·4.2.The write-downs were known for a long time, so they should not have come as a surprise. Apart from that, the report and the outlook are good. Lucky those who bought for 178 today, lucky devils.
·3 päivää sittenHow big is the competition from China? Is it, like, inevitable that they will dominate the market going forward, or is it only in certain product groups they are strong in?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
UUTTA
4 päivää sitten37 min
4,75 NOK/osake
Irtoamispäivä 17.4.
2,48%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·23 t sittenWhat do people think about this company going forward. Have followed the stock for a long time, but never owned any shares. What are the positives and negatives with the company?·2 t sittenGood question - Podcast stockup highlights Borregaard as a safe haven, unique products, strong financials and robust. Increased dividend for a long time and approaching an aristocrat. I don't own the stock myself, followed it from the sidelines. The last I heard was a one-off cost that many viewed negatively. Hope this was helpful. Last tip look at P/E and forward P/E and forward Eps growth.
- ·2 päivää sittenYes, they delivered a bit weaker than expected and yes, they face competition from the Chinese. But they also delivered the best ebitda ever (just barely) in 2025. Fortunately, the price targets are far above today's price, so with a little patience, this will probably calm down soon and the bottom will be reached. The same happened with Link and they are now somewhat on their way up again. I have faith·2 päivää sittenThe crucial point was not that China exists – they have done so for a long time – but that: Management for the first time explicitly guided price decline (–3–4 % H1 2026) in Biomaterials The sentence about Chinese imports affecting European producers was stated black on white in the presentation This hit a market that was positioned for price increases, not decreases The market interpreted this as potentially structural, not just cyclical.·2 päivää sittenYeah, I caught that. China has been discussed many times before, but this was the first time they included it in the report. So maybe they are feeling the competition more now than before, that's possible. The decline is due, as you say, to the fact that market participants expected a price increase for biomaterials (vanillin) while the company announced a decrease. Let's hope they were a bit conservative in their guiding.
- 2 päivää sitten2 päivää sittenDo we hold the line, or is it the last man out the door to turn the lights off? Where are the triggers ?
- ·3 päivää sittenABG Sundal Collier BUY price target 210 kroner (220) recommendation after the fourth-quarter report, according to an update Thursday. DNB Carnegie BUY unchanged price target of 240 kroner, according to an update Wednesday. Danske Bank HOLD price target 195 kroner (215), according to an update Wednesday. Pareto Securities reiterates HOLD price target 196 kroner (208) SEB downgrades to HOLD , price target to 200 kroner (230). https://www.nordnet.no/market/news/601bb631-5543-45b4-a4aa-89c4c048ebf5 . https://www.nordnet.no/market/news/ed81d193-c4ec-44c0-ab1c-7bd893df389f
- ·4.2.The write-downs were known for a long time, so they should not have come as a surprise. Apart from that, the report and the outlook are good. Lucky those who bought for 178 today, lucky devils.·3 päivää sittenHow big is the competition from China? Is it, like, inevitable that they will dominate the market going forward, or is it only in certain product groups they are strong in?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
5
Myynti
Määrä
220
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 174 | - | - | ||
| 100 | - | - | ||
| 125 | - | - | ||
| 125 | - | - |
Ylin
173VWAP
Alin
168,2VaihtoMäärä
21,8 128 683
VWAP
Ylin
173Alin
168,2VaihtoMäärä
21,8 128 683
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2026 Q1 -tulosraportti | 29.4. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q4 -tulosraportti | 4.2. | |
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 16.7.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 29.1.2025 |
2025 Q4 -tulosraportti
UUTTA
4 päivää sitten37 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2026 Q1 -tulosraportti | 29.4. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q4 -tulosraportti | 4.2. | |
| 2025 Q3 -tulosraportti | 22.10.2025 | |
| 2025 Q2 -tulosraportti | 16.7.2025 | |
| 2025 Q1 -tulosraportti | 30.4.2025 | |
| 2024 Q4 -tulosraportti | 29.1.2025 |
4,75 NOK/osake
Irtoamispäivä 17.4.
2,48%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·23 t sittenWhat do people think about this company going forward. Have followed the stock for a long time, but never owned any shares. What are the positives and negatives with the company?·2 t sittenGood question - Podcast stockup highlights Borregaard as a safe haven, unique products, strong financials and robust. Increased dividend for a long time and approaching an aristocrat. I don't own the stock myself, followed it from the sidelines. The last I heard was a one-off cost that many viewed negatively. Hope this was helpful. Last tip look at P/E and forward P/E and forward Eps growth.
- ·2 päivää sittenYes, they delivered a bit weaker than expected and yes, they face competition from the Chinese. But they also delivered the best ebitda ever (just barely) in 2025. Fortunately, the price targets are far above today's price, so with a little patience, this will probably calm down soon and the bottom will be reached. The same happened with Link and they are now somewhat on their way up again. I have faith·2 päivää sittenThe crucial point was not that China exists – they have done so for a long time – but that: Management for the first time explicitly guided price decline (–3–4 % H1 2026) in Biomaterials The sentence about Chinese imports affecting European producers was stated black on white in the presentation This hit a market that was positioned for price increases, not decreases The market interpreted this as potentially structural, not just cyclical.·2 päivää sittenYeah, I caught that. China has been discussed many times before, but this was the first time they included it in the report. So maybe they are feeling the competition more now than before, that's possible. The decline is due, as you say, to the fact that market participants expected a price increase for biomaterials (vanillin) while the company announced a decrease. Let's hope they were a bit conservative in their guiding.
- 2 päivää sitten2 päivää sittenDo we hold the line, or is it the last man out the door to turn the lights off? Where are the triggers ?
- ·3 päivää sittenABG Sundal Collier BUY price target 210 kroner (220) recommendation after the fourth-quarter report, according to an update Thursday. DNB Carnegie BUY unchanged price target of 240 kroner, according to an update Wednesday. Danske Bank HOLD price target 195 kroner (215), according to an update Wednesday. Pareto Securities reiterates HOLD price target 196 kroner (208) SEB downgrades to HOLD , price target to 200 kroner (230). https://www.nordnet.no/market/news/601bb631-5543-45b4-a4aa-89c4c048ebf5 . https://www.nordnet.no/market/news/ed81d193-c4ec-44c0-ab1c-7bd893df389f
- ·4.2.The write-downs were known for a long time, so they should not have come as a surprise. Apart from that, the report and the outlook are good. Lucky those who bought for 178 today, lucky devils.·3 päivää sittenHow big is the competition from China? Is it, like, inevitable that they will dominate the market going forward, or is it only in certain product groups they are strong in?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
5
Myynti
Määrä
220
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 174 | - | - | ||
| 100 | - | - | ||
| 125 | - | - | ||
| 125 | - | - |
Ylin
173VWAP
Alin
168,2VaihtoMäärä
21,8 128 683
VWAP
Ylin
173Alin
168,2VaihtoMäärä
21,8 128 683
Välittäjätilasto
Dataa ei löytynyt